Alpha 2.0
Login Register
» Articles » PMID: 4436788

Quantitative GLC Determination of Cyclophosphamide and Isophosphamide in Biological Specimens

Overview
Journal J Pharm Sci
Publisher Elsevier
Specialties Pharmacology
Pharmacy
Date 1974 Oct 1
PMID 4436788
Citations 10
Authors
C Pantarotto
A Bossi
G Belvedere
A Martini
M G Donelli
A Frigerio
Affiliations
Soon will be listed here.
Citing Articles

Repeated investigations of cyclophosphamide disposition in myeloma patients receiving intermittent chemotherapy.

Edwards G, Calvert R, Crowther D, Bramwell V, Scarffe H Br J Clin Pharmacol. 1980; 10(3):281-5.

PMID: 7437246 PMC: 1430067. DOI: 10.1111/j.1365-2125.1980.tb01756.x.

Decreased plasma half-life of cyclophosphamide during repeated high-dose administration.

Graham M, Shaw I, Souhami R, Sidau B, Harper P, McLean A Cancer Chemother Pharmacol. 1983; 10(3):192-3.

PMID: 6861264 DOI: 10.1007/BF00255760.

Pharmacokinetics of high-dose cyclophosphamide in patients with metastatic bronchogenic carcinoma.

Wilkinson P, ONeill P, Thatcher N, Lucas S Cancer Chemother Pharmacol. 1983; 11(3):196-9.

PMID: 6640827 DOI: 10.1007/BF00254204.

Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide.

Evelo C, Bos R, Peters J, Henderson P Int Arch Occup Environ Health. 1986; 58(2):151-5.

PMID: 3744569 DOI: 10.1007/BF00380766.

Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility.

Cerny T, Graf A, Rohner P, Zeugin T, BRUNNER K, Kupfer A J Cancer Res Clin Oncol. 1991; 117 Suppl 4:S129-34.

PMID: 1795001 DOI: 10.1007/BF01613217.